With AcrySof® IQ PanOptix® IOL, you may reduce your dependence for spectacles after cataract surgery.1
Once both eyes have been treated, most people find they have good vision at near, intermediate, and far distances without glasses within a few days of the surgery.1,2 You may experience some visual disturbances, especially under dim light conditions. However, these disturbances are expected to disappear over time after the surgery.3,4
After your vision settles, PanOptix® IOL is designed to help you enjoy most of your daily activities without glasses, including:1,2,5-9
There is no intraocular lens that exactly mimics a young eye. But next-generation trifocal lenses offer the latest advances in vision technology. They are designed to enhance your lifestyle by providing clear vision at near, intermediate, and far distances.1,2,5-10
AcrySof® IQ PanOptix® IOL is designed to provide good vision in most day-to-day situations without the need for glasses.1,2,5-10
You may still need glasses for some specific tasks. This is common to all intraocular lenses.
The AcrySof® IQ PanOptix® Presbyopia Correcting Intraocular Lens is intended for primary implantation in the capsular bag in the posterior chamber for the visual correction of aphakia secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision with increased spectacle independence.
As with any surgical procedure, there are associated risks. Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens of this type. This is particularly so in a patient with any of the conditions described in the AcrySof® IQ PanOptix® physician labeling. Some patients may experience visual disturbances and/or difficulty seeing due to the multifocal lens design, especially under dim light conditions. As with other multifocal IOLs, visual symptoms may be significant enough that the patient will request explantation of an AcrySof® IQ PanOptix® IOL. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than in patients with monofocal IOLs.
Refer to the Directions for Use labeling for Model TFNT00 for a complete listing of indications, warnings and precautions.